These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16942762)

  • 1. Design, synthesis and activity as acid ceramidase inhibitors of 2-oxooctanoyl and N-oleoylethanolamine analogues.
    Grijalvo S; Bedia C; Triola G; Casas J; Llebaria A; Teixidó J; Rabal O; Levade T; Delgado A; Fabriàs G
    Chem Phys Lipids; 2006 Oct; 144(1):69-84. PubMed ID: 16942762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of cyclopropene analogues of ceramide and their effect on dihydroceramide desaturase.
    Triola G; Fabriàs G; Casas J; Llebaria A
    J Org Chem; 2003 Dec; 68(26):9924-32. PubMed ID: 14682684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a novel ceramide analogue and its use in a high-throughput fluorogenic assay for ceramidases.
    Bedia C; Casas J; Garcia V; Levade T; Fabriàs G
    Chembiochem; 2007 Apr; 8(6):642-8. PubMed ID: 17361980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity and acid ceramidase inhibitory activity of 2-substituted aminoethanol amides.
    Bedia C; Canals D; Matabosch X; Harrak Y; Casas J; Llebaria A; Delgado A; Fabriás G
    Chem Phys Lipids; 2008 Nov; 156(1-2):33-40. PubMed ID: 18760267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel metalloproteinase inhibitors.
    Nakatani S; Ikura M; Yamamoto S; Nishita Y; Itadani S; Habashita H; Sugiura T; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M
    Bioorg Med Chem; 2006 Aug; 14(15):5402-22. PubMed ID: 16621578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a new chemical lead for a matrix metalloproteinase inhibitor.
    Ikura M; Nakatani S; Yamamoto S; Habashita H; Sugiura T; Takahashi K; Ogawa K; Ohno H; Nakai H; Toda M
    Bioorg Med Chem; 2006 Jun; 14(12):4241-52. PubMed ID: 16481176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
    Tomoda H; Doi T
    Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel amide- and sulfonamide-based aromatic ethanolamines: effects of various substituents on the inhibition of acid and neutral ceramidases.
    Bhabak KP; Arenz C
    Bioorg Med Chem; 2012 Oct; 20(20):6162-70. PubMed ID: 22989912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors.
    Stewart AO; Bhatia PA; Martin JG; Summers JB; Rodriques KE; Martin MB; Holms JH; Moore JL; Craig RA; Kolasa T; Ratajczyk JD; Mazdiyasni H; Kerdesky FA; DeNinno SL; Maki RG; Bouska JB; Young PR; Lanni C; Bell RL; Carter GW; Brooks CD
    J Med Chem; 1997 Jun; 40(13):1955-68. PubMed ID: 9207936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting (cellular) lysosomal acid ceramidase by B13: design, synthesis and evaluation of novel DMG-B13 ester prodrugs.
    Bai A; Szulc ZM; Bielawski J; Pierce JS; Rembiesa B; Terzieva S; Mao C; Xu R; Wu B; Clarke CJ; Newcomb B; Liu X; Norris J; Hannun YA; Bielawska A
    Bioorg Med Chem; 2014 Dec; 22(24):6933-44. PubMed ID: 25456083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease.
    Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V
    Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
    Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
    Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship studies of novel oxygen-incorporated SAHA analogues.
    Kim SA; Jin YL; Kim HS
    Arch Pharm Res; 2009 Jan; 32(1):15-21. PubMed ID: 19183872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors.
    Suzuki N; Suzuki T; Ota Y; Nakano T; Kurihara M; Okuda H; Yamori T; Tsumoto H; Nakagawa H; Miyata N
    J Med Chem; 2009 May; 52(9):2909-22. PubMed ID: 19419205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
    Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of rho kinase inhibitors (III).
    Iwakubo M; Takami A; Okada Y; Kawata T; Tagami Y; Sato M; Sugiyama T; Fukushima K; Taya S; Amano M; Kaibuchi K; Iijima H
    Bioorg Med Chem; 2007 Jan; 15(2):1022-33. PubMed ID: 17084087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective inhibition of acid and neutral ceramidases by novel B-13 and LCL-464 analogues.
    Bhabak KP; Kleuser B; Huwiler A; Arenz C
    Bioorg Med Chem; 2013 Feb; 21(4):874-82. PubMed ID: 23312611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights on the use of desipramine as an inhibitor for acid ceramidase.
    Elojeimy S; Holman DH; Liu X; El-Zawahry A; Villani M; Cheng JC; Mahdy A; Zeidan Y; Bielwaska A; Hannun YA; Norris JS
    FEBS Lett; 2006 Aug; 580(19):4751-6. PubMed ID: 16901483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
    Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
    Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells.
    Holman DH; Turner LS; El-Zawahry A; Elojeimy S; Liu X; Bielawski J; Szulc ZM; Norris K; Zeidan YH; Hannun YA; Bielawska A; Norris JS
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):231-42. PubMed ID: 17429631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.